Agomelatine or placebo as adjunctive therapy to a mood stabiliser in bipolar I depression: randomised double-blind placebo-controlled trial
Another important white space is represented by the emergence of comorbidity-driven positioning of oral obesity drugs, which allows marketing such medicines as treatment not only for weight loss but also for obesity associated with type 2 diabetes, cardiovascular risks, metabolic syndrome, and MASH
Mechanisms of contact sensitization offer insights into the role of barrier defects vs
Marketing and safety concerns for compounded GLP-1 receptor agonists
Booking opens soon
In the Gut & Autoimmune Reset, I tell you exactly what to do so you can open drainage and detox pathways to improve energy and digestion while preparing your body for the next step in removing and eliminating pathogens, infections, and toxins, such as mold